Page last updated: 2024-11-08

biguanides and Myocardial Ischemia

biguanides has been researched along with Myocardial Ischemia in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Margolis, DJ1
Hoffstad, O1
Strom, BL1
Monami, M1
Marchionni, N1
Masotti, G1
Mannucci, E1

Other Studies

2 other studies available for biguanides and Myocardial Ischemia

ArticleYear
Association between serious ischemic cardiac outcomes and medications used to treat diabetes.
    Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:8

    Topics: Adult; Aged; Biguanides; Cohort Studies; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Ins

2008
Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease.
    International journal of cardiology, 2008, May-23, Volume: 126, Issue:2

    Topics: Aged; Biguanides; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Foll

2008